.jpg)
.png)
I’m always reminded of how fortunate I have been to serve the National Lipid Association (NLA) in various capacities and to watch the organization grow and mature over time. I have seen tremendous growth in member engagement in various NLA activities, as well as a renewed sense of comradery and purpose.
Article By:
Past President, NLA, 2014-15
Professor of Medicine
Director, Office of Health Promotion
& Disease Prevention
Emory University
Atlanta, GA
Diplomate, American Board
of Clinical Lipidology
I was asked to write a perspective on a look back of the past five years on the NLA and clinical lipidology. It is impossible to state all the advances made in clinical lipidology and the contributions our organization has made over the past five years in a short and focused perspective. Therefore, I decided to constrain my perspective to those advancements made in one of the highest risk populations, familial hypercholesterolemia (FH)-not surprising for those who know me well.
Article By:
NLA Past President, 2013-14
Sanofi DCV Medical Affairs
Sanofi US
Portland, OR
Lipid therapeutics over the past three decades have focused on oral drugs that targeted lipid metabolism through mechanisms that regulate clearance of apoprotein B-containing lipoproteins (through the LDL receptor, such as statins, bile acid resins and ezetimibe) or the synthesis/clearance of triglyceride-containing lipoproteins (such as fibrates, niacin and omega 3 fatty acids).
Article By:
Chief Science Officer
National Lipid Association
Associate Professor of Medicine
Co-Director, Lipid Metabolism & Atherosclerosis Clinic Center for Cardiovascular Disease Prevention
Houston Methodist DeBakey Heart & Vascular Center
Baylor College of Medicine
Houston, TX
Diplomate, American Board of Clinical Lipidology
Chief Executive Officer
National Clinical Research, Inc.
Manakin Sabot, VA
I am both honored and humbled to be chosen as your next president of SELA. I am fully aware I walk in the footsteps of giants in the field.
When reflecting on the direction of SELA over the next year, three words come to mind – diversity, disparities and dissemination. First, it is my hope that we can continue to increase our membership by inviting potential members of all eligible disciplines.
I am extremely honored and excited to be the President of the MWLA for this next year.
2017 has certainly been the year of change, whether speaking about politics, sports, or medicine. Change can be exciting, stimulating, but sometimes frightening when not prepared for the change.
Responses from healthcare workers show significant barriers to prescriptions
PCSK9 Inhibitors Survey Findings Infographic Download
PCSK9 Inhibitors Approval Checklist Download
James A. Underberg, MD, MS, Elected President during the 2017 NLA Scientific Sessions in Philadelphia
PHILADELPHIA, Pa. — The National Lipid Association (NLA) announced the election of new President James A. Underberg, MD, MS, FACPM, FACP, FASPC, FNLA, on Saturday at the 2017 Scientific Sessions in Philadelphia.
FOURIER Trial Reveals Significant Reduction in Cardiovascular Risk
Study results indicate that evolocumab significantly reduces the risk of cardiovascular events in patients with clinically evident ASCVD
Registration Open for the NLA Scientific Sessions Register for the National Lipid Association’s annual Scientific Sessions May 18–21, 2017, at the Philadelphia Marriott Downtown. Don’t miss featured sessions on: Genetic Scoring and Cardiovascular Risk, Treatment and Developing Therapies in FH, PCSK9 Outcomes Studies, and many more.
Article By:
Sonja Connor, MS, RDN, LN, began her journey with the National Lipid Association in the summer of 2009 and served on the Pacific Lipid Board from 2009–2010. When Sonja found out she was selected for the member spotlight she was elated and provided a very detailed glimpse into her life. Sonja’s contributions are geared to the advancement of lifestyle changes as her prime focus to combat coronary disease.
Article By:
Research Associate Professor
Endocrinology, Diabetes & Clinical Nutrition
Oregon Health & Science University
Portland, OR